Ulipristal 相關新聞

← 返回新聞總覽


Ulipristal 目前有 1 則相關新聞報導,預測適應症 20 個。

本頁整合 Ulipristal 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Emergency contraception within 120 hours (five days) of unprotected sexual intercourse or contraceptive failure.
  • 證據等級:L5
  • 預測適應症(20 個):
    • rheumatoid arthritis(90.3%)
    • primary release disorder of platelets(89.7%)
    • tendinitis(89.0%)
    • myositis fibrosa(88.0%)
    • idiopathic granulomatous myositis(88.0%)
    • pseudo-von Willebrand disease(87.2%)
    • Glanzmann thrombasthenia(87.0%)
    • brachydactyly-syndactyly syndrome(86.8%)
    • colobomatous microphthalmia-rhizomelic dysplasia syndrome(86.1%)
    • fibromyalgia(85.6%)
    • heart neoplasm(85.0%)
    • scalp dermatosis(84.6%)
    • thrombotic disease(83.8%)
    • indolent plasma cell myeloma(83.8%)
    • inclusion body myositis(83.5%)
    • amenorrhea (disease)(82.9%)
    • heart conduction disease(82.4%)
    • plasma cell myeloma(82.3%)
    • congenital anomaly of ventricular septum(82.1%)
    • conjunctivitis(82.0%)

查看完整藥物報告 →

相關新聞(1 則)

DGIM 2026: Arthralgie oder Arthritis? Differenzialdiagnostik schmerzhafter Gelenke - Gelbe Liste

2026-04-27 arthritis AF

來源:Gelbe Liste


免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.